The use of natalizumab for multiple sclerosis
Rachel Brandstadter, Ilana Katz Sand Department of Neurology, Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Icahn School of Medicine at Mount Sinai, New York, NY, USA Abstract: Natalizumab is a monoclonal antibody that acts as an α4 integrin antagonist to prevent leukocyte t...
Guardado en:
Autores principales: | Brandstadter R, Katz Sand I |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/57556eede1514bf2982d42266f37def7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Natalizumab administration in multiple sclerosis patients during active SARS-CoV-2 infection: a case series
por: Clara G. Chisari, et al.
Publicado: (2021) -
Prevalence and burden of multiple sclerosis-related fatigue: a systematic literature review
por: Abril Oliva Ramirez, et al.
Publicado: (2021) -
The hospital anxiety and depression scale, in patients with multiple sclerosis
por: Pais-Ribeiro JL, et al.
Publicado: (2018) -
The role of microglia in multiple sclerosis
por: Luo C, et al.
Publicado: (2017) -
Impact of Andropause on Multiple Sclerosis
por: Maria C. Ysrraelit, et al.
Publicado: (2021)